Xie, J., Wang, Y., Popoli, M., Ptak, J., Dobbyn, L., Silliman, N., Pasca, S., Paul, S., Jones, R., Levis, M., Curtis, S., Douville, C., Guo, M., Mo, S., Gocke, C., Malek, S., Bettegowda, C., Bollard, C., Kinzler, K., Vogelstein, B., Papadopoulos, N., Gondek, L. (2025). A plasma-based test for the measurable residual disease informs the response to treatment in AML patients. Blood. https://doi.org/10.1182/blood-2025-1743